Podcast 38: CDMOs/CMOs Expand High-Potency API Manufacturing

Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments. Key topics: (see Chapter Markers…

Podcast 37: Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?

A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals. Key topics: (see Chapter Markers in drop down…

Podcast 36: CDMOs/CMOs Ramp Up Biomanufacturing Capacity

Capital investments are ramping up in biomanufacturing, which continues to be an active area for CDMOs/CMOs in both traditional biologics and new modalities. Which companies are expanding? Key topics: (see…

Podcast 35: How Can Today’s Supply-Chain Challenges Be Fixed?

A DCAT Week program brings together leading Bio/Pharma executives to offer their perspectives on how Bio/Pharma companies and their suppliers are adjusting supply practices now and in the near term.…

Podcast 33: Rising Energy Costs and API Supply

Escalating energy prices are impacting global manufacturing and supply chains. In the EU, leaders are proposing measures to alleviate energy pricing pressures. What’s the plan in the EU and the…

Podcast 32: Blockbuster Muscle: Small Molecules or Biologics?

Which modality, small molecules or biologics, leads among the top-selling products? A look at the top-selling products industry-wide and blockbusters from select leading bio/pharma companies provides the answer. For the…